Author

Pingdong Tao

Stanford Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell signaling & trafficking· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Hua JiangiD· 3 shared K. Christopher GarcíaiD· 3 shared Kevin M. JudeiD· 2 shared Leon SuiD· 2 shared Yang ZhaoiD· 2 shared Aastha PaliD· 1 shared Ada WongiD· 1 shared Anshul Bharat KundajeiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Hua JiangORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Cytokine Receptor Signaling Atlas Reveals How STAT Mosaics Fine-Tune T Cell Function

Pingdong Tao, Ruchir Rastogi, Hua Jiang, Yang Zhao, Leon Su, Kevin M. Jude, Anshul Bharat Kundaje, K. Christopher García

A fully orthogonal IL-2 receptor platform isolates 36 cytokine receptors in T cells; receptor-specific STAT combinations specify distinct fates, and STAT3-dominant programs give curative antitumor responses.

bioRxiv · Aug 24, 2026 · PreprintImmunology✦ In-depth digest

All-by-All Cytokine Receptor Pairing Network Unlocks Coding of Non-Natural T Cell States

Pingdong Tao, Kristin CY Tsui, Yang Zhao, Hua Jiang, Zinaida Good, K. Christopher García

The paper uses synthetic cytokine receptor pairings to generate novel T cell states with distinct functions, revealing how pairing orientation and STAT combinatorics influence cell fate.

bioRxiv · Aug 24, 2026 · PreprintImmunology

IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy

Hua Jiang, Sam P. Limsuwannarot, Kayla R. Kulhanek, Aastha Pal, Ossama Labiad, Lea Wenting Rysavy, Ada Wong, Leon Su, Sarah M. Cavender, Johnathon Soro, Stefano Testa, Heather Anne N. Ogana, Deepa Waghray, Pingdong Tao, Kevin M. Jude, , Anusha K. Kalbasi

The paper shows that T cells engineered with IL-9R have better tissue infiltration, stemness, and anti-tumor activity compared to those with an orthogonal IL-9 receptor, due to stronger and more specific JAK/STAT signaling.

Immunity · Nov 21, 2025Peer-reviewedImmunology